Copyright Reports & Markets. All rights reserved.

Global Preclinical CRO Treatment Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Bioanalysis and DMPK Studies
    • 1.2.3 Toxicology Testing
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Preclinical CRO Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Biopharmaceutical Companies
    • 1.3.3 Government and Academic Institutes
    • 1.3.4 Medical Device Companies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preclinical CRO Treatment Market Perspective (2016-2027)
  • 2.2 Preclinical CRO Treatment Growth Trends by Regions
    • 2.2.1 Preclinical CRO Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Preclinical CRO Treatment Historic Market Share by Regions (2016-2021)
    • 2.2.3 Preclinical CRO Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Preclinical CRO Treatment Industry Dynamic
    • 2.3.1 Preclinical CRO Treatment Market Trends
    • 2.3.2 Preclinical CRO Treatment Market Drivers
    • 2.3.3 Preclinical CRO Treatment Market Challenges
    • 2.3.4 Preclinical CRO Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preclinical CRO Treatment Players by Revenue
    • 3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2016-2021)
    • 3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2016-2021)
  • 3.2 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Preclinical CRO Treatment Revenue
  • 3.4 Global Preclinical CRO Treatment Market Concentration Ratio
    • 3.4.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2020
  • 3.5 Preclinical CRO Treatment Key Players Head office and Area Served
  • 3.6 Key Players Preclinical CRO Treatment Product Solution and Service
  • 3.7 Date of Enter into Preclinical CRO Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Treatment Breakdown Data by Type

  • 4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2022-2027)

5 Preclinical CRO Treatment Breakdown Data by Application

  • 5.1 Global Preclinical CRO Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Preclinical CRO Treatment Market Size (2016-2027)
  • 6.2 North America Preclinical CRO Treatment Market Size by Type
    • 6.2.1 North America Preclinical CRO Treatment Market Size by Type (2016-2021)
    • 6.2.2 North America Preclinical CRO Treatment Market Size by Type (2022-2027)
    • 6.2.3 North America Preclinical CRO Treatment Market Size by Type (2016-2027)
  • 6.3 North America Preclinical CRO Treatment Market Size by Application
    • 6.3.1 North America Preclinical CRO Treatment Market Size by Application (2016-2021)
    • 6.3.2 North America Preclinical CRO Treatment Market Size by Application (2022-2027)
    • 6.3.3 North America Preclinical CRO Treatment Market Size by Application (2016-2027)
  • 6.4 North America Preclinical CRO Treatment Market Size by Country
    • 6.4.1 North America Preclinical CRO Treatment Market Size by Country (2016-2021)
    • 6.4.2 North America Preclinical CRO Treatment Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Preclinical CRO Treatment Market Size (2016-2027)
  • 7.2 Europe Preclinical CRO Treatment Market Size by Type
    • 7.2.1 Europe Preclinical CRO Treatment Market Size by Type (2016-2021)
    • 7.2.2 Europe Preclinical CRO Treatment Market Size by Type (2022-2027)
    • 7.2.3 Europe Preclinical CRO Treatment Market Size by Type (2016-2027)
  • 7.3 Europe Preclinical CRO Treatment Market Size by Application
    • 7.3.1 Europe Preclinical CRO Treatment Market Size by Application (2016-2021)
    • 7.3.2 Europe Preclinical CRO Treatment Market Size by Application (2022-2027)
    • 7.3.3 Europe Preclinical CRO Treatment Market Size by Application (2016-2027)
  • 7.4 Europe Preclinical CRO Treatment Market Size by Country
    • 7.4.1 Europe Preclinical CRO Treatment Market Size by Country (2016-2021)
    • 7.4.2 Europe Preclinical CRO Treatment Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Preclinical CRO Treatment Market Size (2016-2027)
  • 8.2 Asia-Pacific Preclinical CRO Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Preclinical CRO Treatment Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Preclinical CRO Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Preclinical CRO Treatment Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Preclinical CRO Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Preclinical CRO Treatment Market Size (2016-2027)
  • 9.2 Latin America Preclinical CRO Treatment Market Size by Type
    • 9.2.1 Latin America Preclinical CRO Treatment Market Size by Type (2016-2021)
    • 9.2.2 Latin America Preclinical CRO Treatment Market Size by Type (2022-2027)
    • 9.2.3 Latin America Preclinical CRO Treatment Market Size by Type (2016-2027)
  • 9.3 Latin America Preclinical CRO Treatment Market Size by Application
    • 9.3.1 Latin America Preclinical CRO Treatment Market Size by Application (2016-2021)
    • 9.3.2 Latin America Preclinical CRO Treatment Market Size by Application (2022-2027)
    • 9.3.3 Latin America Preclinical CRO Treatment Market Size by Application (2016-2027)
  • 9.4 Latin America Preclinical CRO Treatment Market Size by Country
    • 9.4.1 Latin America Preclinical CRO Treatment Market Size by Country (2016-2021)
    • 9.4.2 Latin America Preclinical CRO Treatment Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Preclinical CRO Treatment Market Size (2016-2027)
  • 10.2 Middle East & Africa Preclinical CRO Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Preclinical CRO Treatment Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Preclinical CRO Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Preclinical CRO Treatment Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Preclinical CRO Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Charles River Laboratories
    • 11.1.1 Charles River Laboratories Company Details
    • 11.1.2 Charles River Laboratories Business Overview
    • 11.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction
    • 11.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.1.5 Charles River Laboratories Recent Development
  • 11.2 Laboratory Corporation of America
    • 11.2.1 Laboratory Corporation of America Company Details
    • 11.2.2 Laboratory Corporation of America Business Overview
    • 11.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction
    • 11.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.2.5 Laboratory Corporation of America Recent Development
  • 11.3 Envigo
    • 11.3.1 Envigo Company Details
    • 11.3.2 Envigo Business Overview
    • 11.3.3 Envigo Preclinical CRO Treatment Introduction
    • 11.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.3.5 Envigo Recent Development
  • 11.4 Eurofins Scientific
    • 11.4.1 Eurofins Scientific Company Details
    • 11.4.2 Eurofins Scientific Business Overview
    • 11.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction
    • 11.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.4.5 Eurofins Scientific Recent Development
  • 11.5 PRA Health Science
    • 11.5.1 PRA Health Science Company Details
    • 11.5.2 PRA Health Science Business Overview
    • 11.5.3 PRA Health Science Preclinical CRO Treatment Introduction
    • 11.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.5.5 PRA Health Science Recent Development
  • 11.6 Wuxi AppTec
    • 11.6.1 Wuxi AppTec Company Details
    • 11.6.2 Wuxi AppTec Business Overview
    • 11.6.3 Wuxi AppTec Preclinical CRO Treatment Introduction
    • 11.6.4 Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.6.5 Wuxi AppTec Recent Development
  • 11.7 Medpace
    • 11.7.1 Medpace Company Details
    • 11.7.2 Medpace Business Overview
    • 11.7.3 Medpace Preclinical CRO Treatment Introduction
    • 11.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.7.5 Medpace Recent Development
  • 11.8 Pharmaceutical Product Development
    • 11.8.1 Pharmaceutical Product Development Company Details
    • 11.8.2 Pharmaceutical Product Development Business Overview
    • 11.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction
    • 11.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.8.5 Pharmaceutical Product Development Recent Development
  • 11.9 Paraxel
    • 11.9.1 Paraxel Company Details
    • 11.9.2 Paraxel Business Overview
    • 11.9.3 Paraxel Preclinical CRO Treatment Introduction
    • 11.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2016-2021)
    • 11.9.5 Paraxel Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Preclinical CRO Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical CRO Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Bioanalysis and DMPK Studies
    Toxicology Testing
    Others

    Segment by Application
    Biopharmaceutical Companies
    Government and Academic Institutes
    Medical Device Companies

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Charles River Laboratories
    Laboratory Corporation of America
    Envigo
    Eurofins Scientific
    PRA Health Science
    Wuxi AppTec
    Medpace
    Pharmaceutical Product Development
    Paraxel
    Eurofins Scientific

    Buy now